270 related articles for article (PubMed ID: 18681776)
1. Pharmacogenomic importance of ABCG2.
Cusatis G; Sparreboom A
Pharmacogenomics; 2008 Aug; 9(8):1005-9. PubMed ID: 18681776
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo evidence for the importance of breast cancer resistance protein transporters (BCRP/MXR/ABCP/ABCG2).
Meyer zu Schwabedissen HE; Kroemer HK
Handb Exp Pharmacol; 2011; (201):325-71. PubMed ID: 21103975
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2.
Lepper ER; Nooter K; Verweij J; Acharya MR; Figg WD; Sparreboom A
Pharmacogenomics; 2005 Mar; 6(2):115-38. PubMed ID: 15882131
[TBL] [Abstract][Full Text] [Related]
4. ABCG2 -- a transporter for all seasons.
Sarkadi B; Ozvegy-Laczka C; Német K; Váradi A
FEBS Lett; 2004 Jun; 567(1):116-20. PubMed ID: 15165903
[TBL] [Abstract][Full Text] [Related]
5. Role of ABCG2/BCRP in biology and medicine.
Krishnamurthy P; Schuetz JD
Annu Rev Pharmacol Toxicol; 2006; 46():381-410. PubMed ID: 16402910
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol potentiates ABCG2 activity in a heterologous expression system: improved in vitro model to study function of human ABCG2.
Pál A; Méhn D; Molnár E; Gedey S; Mészáros P; Nagy T; Glavinas H; Janáky T; von Richter O; Báthori G; Szente L; Krajcsi P
J Pharmacol Exp Ther; 2007 Jun; 321(3):1085-94. PubMed ID: 17347325
[TBL] [Abstract][Full Text] [Related]
7. Role of the breast cancer resistance protein (ABCG2) in drug transport.
Mao Q; Unadkat JD
AAPS J; 2005 May; 7(1):E118-33. PubMed ID: 16146333
[TBL] [Abstract][Full Text] [Related]
8. Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2.
Mizuarai S; Aozasa N; Kotani H
Int J Cancer; 2004 Mar; 109(2):238-46. PubMed ID: 14750175
[TBL] [Abstract][Full Text] [Related]
9. The role of human ABC transporter ABCG2 (BCRP) in pharmacotherapy.
Ishikawa T
Adv Drug Deliv Rev; 2009 Jan; 61(1):1-2. PubMed ID: 19124052
[No Abstract] [Full Text] [Related]
10. Effect of Walker A mutation (K86M) on oligomerization and surface targeting of the multidrug resistance transporter ABCG2.
Henriksen U; Gether U; Litman T
J Cell Sci; 2005 Apr; 118(Pt 7):1417-26. PubMed ID: 15769853
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomics of MRP transporters (ABCC1-5) and BCRP (ABCG2).
Gradhand U; Kim RB
Drug Metab Rev; 2008; 40(2):317-54. PubMed ID: 18464048
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics of ATP-binding cassette transporters and clinical implications.
Cascorbi I; Haenisch S
Methods Mol Biol; 2010; 596():95-121. PubMed ID: 19949922
[TBL] [Abstract][Full Text] [Related]
13. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.
Leslie EM; Deeley RG; Cole SP
Toxicol Appl Pharmacol; 2005 May; 204(3):216-37. PubMed ID: 15845415
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics of ABCG2 and adverse reactions to gefitinib.
Cusatis G; Gregorc V; Li J; Spreafico A; Ingersoll RG; Verweij J; Ludovini V; Villa E; Hidalgo M; Sparreboom A; Baker SD
J Natl Cancer Inst; 2006 Dec; 98(23):1739-42. PubMed ID: 17148776
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer resistance protein (ABCG2) in clinical pharmacokinetics and drug interactions: practical recommendations for clinical victim and perpetrator drug-drug interaction study design.
Lee CA; O'Connor MA; Ritchie TK; Galetin A; Cook JA; Ragueneau-Majlessi I; Ellens H; Feng B; Taub ME; Paine MF; Polli JW; Ware JA; Zamek-Gliszczynski MJ
Drug Metab Dispos; 2015 Apr; 43(4):490-509. PubMed ID: 25587128
[TBL] [Abstract][Full Text] [Related]
16. ABCG2: structure, function and role in drug response.
Polgar O; Robey RW; Bates SE
Expert Opin Drug Metab Toxicol; 2008 Jan; 4(1):1-15. PubMed ID: 18370855
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of ATP-binding cassette transporters ABCB1 and ABCC2 and their impact on drug disposition.
Haufroid V
Curr Drug Targets; 2011 May; 12(5):631-46. PubMed ID: 21039333
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance.
Bruhn O; Cascorbi I
Expert Opin Drug Metab Toxicol; 2014 Oct; 10(10):1337-54. PubMed ID: 25162314
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer resistance protein in pharmacokinetics and drug-drug interactions.
Xia CQ; Yang JJ; Gan LS
Expert Opin Drug Metab Toxicol; 2005 Dec; 1(4):595-611. PubMed ID: 16863427
[TBL] [Abstract][Full Text] [Related]
20. Ins and outs of the ABCG2 multidrug transporter: an update on in vitro functional assays.
Hegedus C; Szakács G; Homolya L; Orbán TI; Telbisz A; Jani M; Sarkadi B
Adv Drug Deliv Rev; 2009 Jan; 61(1):47-56. PubMed ID: 19135105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
